View in: PubMed Mentions: 52 Fields: Translation:Humans A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion
1 The general public guidance is conservative because it covers all GLP-1 medications, including those without breast milk data
Research increasingly shows that loss of muscle mass and strength has an adverse impact on health, particularly during aging
Stay hydrated by drinking plenty of water: Aim for 30 mL of fluids per kilogram of body weight, as Semaglutide can cause constipation and dry stools if not properly hydrated
Effects on cognition and global function were evaluated with the Alzheimers Disease Assessment Scale Cognitive Subscale (ADAS-Cog) and the Clinician Interview-Based Impression of Change with Caregiver Input scale (CIBIC+) at 4, 12, and 24 weeks after the start of injections
European Union EMA status: Not approved